Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anca L Grosu

Showing results (131-140 of 174) with videos related to

Pageof 18
Sort By:
In Vivo (Athens, Greece)|November 4, 2020
Predicting Biochemical Failure in Irradiated Patients With Prostate Cancer by Tumour Volume Measured by Multiparametric MRIBenedict Oerther, Moritz V Buren, Christina M Klein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 19, 2016
ESTRO-ACROP guideline "target delineation of glioblastomas"Maximilian Niyazi, Michael Brada, Anthony J Chalmers, et al.
International Journal of Radiation Oncology, Biology, Physics|April 26, 2022
PSMA-PET- and MRI-Based Focal Dose Escalated Radiation Therapy of Primary Prostate Cancer: Planned Safety Analysis of a Nonrandomized 2-Armed Phase 2 Trial (ARO2020-01)Constantinos Zamboglou, Simon K B Spohn, Juri Ruf, et al.
Theranostics|January 3, 2017
Comparison of <sup>68</sup>Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathologyConstantinos Zamboglou, Vanessa Drendel, Cordula A Jilg, et al.
Oncotarget|January 17, 2019
Oncogenic <i>transgelin-2</i> is differentially regulated in <i>isocitrate dehydrogenase</i> wild-type vs. mutant gliomasSasha J Beyer, Erica H Bell, Joseph P McElroy, et al.
Frontiers in Oncology|September 9, 2020
Immunohistochemistry and Radiomic Features for Survival Prediction in Small Cell Lung CancerEleni Gkika, Matthias Benndorf, Benedict Oerther, et al.
Radiation Oncology (London, England)|February 5, 2021
X-change symposium: status and future of modern radiation oncology-from technology to biologyStefanie Corradini, Maximilian Niyazi, Dirk Verellen, et al.
Radiation Oncology (London, England)|May 3, 2018
Focal dose escalation for prostate cancer using <sup>68</sup>Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology referenceConstantinos Zamboglou, Benedikt Thomann, Khodor Koubar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2020
ESTRO ACROP guideline for target volume delineation of skull base tumorsStephanie E Combs, Brigitta G Baumert, Martin Bendszus, et al.
Theranostics|April 22, 2024
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA-617 for prostate cancer - from bench to bedsideDaria Arbuznikova, Aikaterini Klotsotyra, Lisa Uhlmann, et al.
Pageof 18

Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
In Vivo (Athens, Greece)|November 4, 2020
Predicting Biochemical Failure in Irradiated Patients With Prostate Cancer by Tumour Volume Measured by Multiparametric MRIBenedict Oerther, Moritz V Buren, Christina M Klein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 19, 2016
ESTRO-ACROP guideline "target delineation of glioblastomas"Maximilian Niyazi, Michael Brada, Anthony J Chalmers, et al.
International Journal of Radiation Oncology, Biology, Physics|April 26, 2022
PSMA-PET- and MRI-Based Focal Dose Escalated Radiation Therapy of Primary Prostate Cancer: Planned Safety Analysis of a Nonrandomized 2-Armed Phase 2 Trial (ARO2020-01)Constantinos Zamboglou, Simon K B Spohn, Juri Ruf, et al.
Theranostics|January 3, 2017
Comparison of <sup>68</sup>Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathologyConstantinos Zamboglou, Vanessa Drendel, Cordula A Jilg, et al.
Oncotarget|January 17, 2019
Oncogenic <i>transgelin-2</i> is differentially regulated in <i>isocitrate dehydrogenase</i> wild-type vs. mutant gliomasSasha J Beyer, Erica H Bell, Joseph P McElroy, et al.
Frontiers in Oncology|September 9, 2020
Immunohistochemistry and Radiomic Features for Survival Prediction in Small Cell Lung CancerEleni Gkika, Matthias Benndorf, Benedict Oerther, et al.
Radiation Oncology (London, England)|February 5, 2021
X-change symposium: status and future of modern radiation oncology-from technology to biologyStefanie Corradini, Maximilian Niyazi, Dirk Verellen, et al.
Radiation Oncology (London, England)|May 3, 2018
Focal dose escalation for prostate cancer using <sup>68</sup>Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology referenceConstantinos Zamboglou, Benedikt Thomann, Khodor Koubar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2020
ESTRO ACROP guideline for target volume delineation of skull base tumorsStephanie E Combs, Brigitta G Baumert, Martin Bendszus, et al.
Theranostics|April 22, 2024
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA-617 for prostate cancer - from bench to bedsideDaria Arbuznikova, Aikaterini Klotsotyra, Lisa Uhlmann, et al.
Pageof 18